Effect of Concentrated Growth Factors on Short Implant-Supported Overdentures
Launched by TANTA UNIVERSITY · Mar 16, 2025
Trial Information
Current as of May 09, 2025
Completed
Keywords
ClinConnect Summary
A controlled clinical trial will be performed upon patients attending the outpatient clinic of Faculty of Dentistry Tanta University.Ten male patients will be selected for this study. Split mouth study design will be used in this study where, Group I represented the right side of the patients' mandibular posterior region will be restored with short implant in place of first molar and Group II represented the left side of the patients' mandibular posterior region will be restored with short implant in place of first molar and concentrated growth factors. The patients will receive partial man...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients between 20 to 65 years old. Class I Kennedy's classification Good oral hygiene.
- Exclusion Criteria:
- • Bad oral hygiene. Para functional habits ex. (bruxism, clenching,)
About Tanta University
Tanta University is a prestigious academic institution located in Egypt, dedicated to advancing medical research and education. As a clinical trial sponsor, Tanta University leverages its extensive resources and expertise to conduct innovative research initiatives aimed at improving health outcomes. The university collaborates with a network of healthcare professionals, researchers, and institutions to facilitate rigorous clinical trials across various medical disciplines. Committed to ethical standards and scientific integrity, Tanta University strives to contribute to the global body of knowledge while fostering the next generation of medical professionals.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tanta, Gharbiya, Egypt
Patients applied
Trial Officials
Sherin F Donia, PHD
Principal Investigator
Tanta University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported